Biocept, Inc. (BIOC) Social Stream
Biocept Inc (BIOC) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering BIOC.
|Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
Price Target Last Issued December 3, 2021
The Trend in the Analyst Price Target
Over the past 120 days, BIOC's average price target has gone up $1.
BIOC reports an average of 232.89% for its upside potential over the past 18 months.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Share Price||Upside Potential|
BIOC Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for BIOC as an investment opportunity.
- BIOC has a higher number of analysts covering the stock than nearly none of all US stocks.
- Biocept Inc's upside potential (average analyst target price relative to current price) is greater than 93.02% of all US stocks.
- BIOC has a higher average analyst price target than 14.2% of all US stocks.
- Biocept Inc's variance in analysts' estimates is less than 84.16% of Healthcare stocks.
Is BIOC a Buy, Hold or Sell? See the POWR Ratings now!